NEW YORK, July 28, 2016 /PRNewswire/ -- This report shows inpatient procedure numbers for nuclear medical therapy reported by all German hospitals between 2006 and 2014.
The report focuses on (1) therapy with open radionuclides and (2) radioiodine therapy. Data for more than 50 procedures with open radionuclides and radioiodine therapy are presented. Procedures with open radionuclides are differentiated according to how the nuclides are applied (intra-arterial, intra-venous, interstitial/intraluminal) and which specific nuclides are used in what area of application (e.g. bone metastasis). For Radioiodine therapy the levels of radioactive iodide (I-131) are provided in three groups ( lower 1,2 GBq, 1,2 to 5 GBq, more than 5GBq) and information on the use of recombinant Thyreotropin (rh-TSH) is given. The report provides a general overview of the market size and is further segmented by federal state and procedures per 100.000 inhabitants per federal state. The "Top 5 performers" - hospitals with the most nuclear medical procedures - are identified. These data will support strategic business decisions and guide sales activities.
Read the full report: http://www.reportlinker.com/p03875447-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nuclear-medical-therapy-radioactive-iodine-therapy-and-therapy-with-open-radionuclides---radioactive-substances-and-areas-of-use-a-detailed-analysis-and-trends-of-all-reported-procedures-in-german-hospitals-2006-2008-2010-2-300305993.html